Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond

被引：359
作者：
Kunkel, Gregory T. [1 ]
Maceyka, Michael [1 ]
Milstien, Sheldon [1 ]
Spiegel, Sarah [1 ]
机构：
[1] Virginia Commonwealth Univ, Sch Med, Massey Canc Ctr, Dept Biochem & Mol Biol, Richmond, VA 23298 USA
来源：
NATURE REVIEWS DRUG DISCOVERY | 2013年 / 12卷 / 09期
基金：
美国国家卫生研究院;
关键词：
SPHINGOSINE KINASE 1; SIGNAL-REGULATED KINASE-1/2; PERSISTENT STAT3 ACTIVATION; 1-PHOSPHATE RECEPTORS; TRANSPORTER SPNS2; S1P(1) ANTAGONIST; LYMPHOCYTE TRAFFICKING; ENDOTHELIAL-CELLS; FTY720; INHIBITION;
D O I：
10.1038/nrd4099
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
The bioactive lipid sphingosine-1-phosphate (S1P) is involved in multiple cellular signalling systems and has a pivotal role in the control of immune cell trafficking. As such, S1P has been implicated in disorders such as cancer and inflammatory diseases. This Review discusses the ways in which S1P might be therapeutically targeted - for example, via the development of chemical inhibitors that target the generation, transport and degradation of S1P and via the development of specific S1P receptor agonists. We also highlight recent conflicting results observed in preclinical studies targeting S1P and discuss ongoing clinical trials in this field.
引用
收藏
页码：688 / 702
页数：15
相关论文
共 50 条
  • [31] Sphingosine-1-Phosphate as a Potential Target for the Treatment of Myocardial Infarction
    Waeber, Christian
    Walther, Thomas
    CIRCULATION JOURNAL, 2014, 78 (04) : 795 - 802
  • [32] Sphingosine-1-phosphate: Extracellular mediator or intracellular second messenger?
    Hla, T
    Lee, MJ
    Ancellin, N
    Liu, CH
    Thangada, S
    Thompson, BD
    Kluk, M
    BIOCHEMICAL PHARMACOLOGY, 1999, 58 (02) : 201 - 207
  • [33] Sphingosine-1-phosphate: the Swiss army knife of sphingolipid signaling
    Maceyka, Michael
    Milstien, Sheldon
    Spiegel, Sarah
    JOURNAL OF LIPID RESEARCH, 2009, 50 : S272 - S276
  • [34] Sphingosine kinase and sphingosine-1-phosphate receptors: novel therapeutic targets of rheumatoid arthritis?
    Lai, Wen-Qi
    Chia, Faith Li-Ann
    Leung, Bernard P.
    FUTURE MEDICINAL CHEMISTRY, 2012, 4 (06) : 727 - 733
  • [35] Sphingosine-1-Phosphate and Lymphocyte Egress from Lymphoid Organs
    Cyster, Jason G.
    Schwab, Susan R.
    ANNUAL REVIEW OF IMMUNOLOGY, VOL 30, 2012, 30 : 69 - 94
  • [36] Sphingolipids and Atherosclerosis: The Dual Role of Ceramide and Sphingosine-1-Phosphate
    Piccoli, Marco
    Cirillo, Federica
    Ghiroldi, Andrea
    Rota, Paola
    Coviello, Simona
    Tarantino, Adriana
    La Rocca, Paolo
    Lavota, Ivana
    Creo, Pasquale
    Signorelli, Paola
    Pappone, Carlo
    Anastasia, Luigi
    ANTIOXIDANTS, 2023, 12 (01)
  • [37] Sphingosine-1-phosphate signaling controlling osteoclasts and bone homeostasis
    Ishii, Masaru
    Kikuta, Junichi
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2013, 1831 (01): : 223 - 227
  • [38] Critical role of sphingosine-1-phosphate receptor 2 (S1PR2) in acute vascular inflammation
    Zhang, Guoqi
    Yang, Li
    Kim, Gab Seok
    Ryan, Kieran
    Lu, Shulin
    O'Donnell, Rebekah K.
    Spokes, Katherine
    Shapiro, Nathan
    Aird, William C.
    Kluk, Michael J.
    Yano, Kiichiro
    Sanchez, Teresa
    BLOOD, 2013, 122 (03) : 443 - 455
  • [39] Sphingosine-1-Phosphate Receptor Subtype 2 Signaling in Endothelial Senescence-Associated Functional Impairments and Inflammation
    Jiawei Zhao
    Dante Garcia
    Allison Gartung
    Menq-Jer Lee
    Current Atherosclerosis Reports, 2015, 17
  • [40] Elevation of serum sphingosine-1-phosphate attenuates impaired cardiac function in experimental sepsis
    Coldewey, Sina M.
    Benetti, Elisa
    Collino, Massimo
    Pfeilschifter, Josef
    Sponholz, Christoph
    Bauer, Michael
    Huwiler, Andrea
    Thiemermann, Christoph
    SCIENTIFIC REPORTS, 2016, 6
12345